Ignite Creation Date:
2024-05-06 @ 7:25 PM
Last Modification Date:
2024-10-26 @ 3:06 PM
Study NCT ID:
NCT06009861
Status:
RECRUITING
Last Update Posted:
2023-08-24
First Post:
2023-08-16
Brief Title:
Neoadjuvant Tislelizumab Plus Chemotherapy for Locally Advanced OralOropharyngeal Cancer NeoSPOT
Sponsor:
Peking University Hospital of Stomatology
Organization:
Peking University Hospital of Stomatology
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-06-27
Start Date Type:
ACTUAL
Primary Completion Date:
2024-06-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-08-31
Completion Date Type:
ESTIMATED
First Submit Date:
2023-08-16
First Submit QC Date:
August 22 2023
Study First Post Date:
2023-08-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-08-22
Last Update Post Date:
2023-08-24
Last Update Post Date Type:
ACTUAL